Viveon Health Acquisition Past Earnings Performance
Past criteria checks 0/6
Viveon Health Acquisition's earnings have been declining at an average annual rate of -124.3%, while the Capital Markets industry saw earnings growing at 9.7% annually.
Key information
-124.3%
Earnings growth rate
-148.0%
EPS growth rate
| Capital Markets Industry Growth | 10.3% |
| Revenue growth rate | n/a |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Viveon Health Acquisition makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 0 | -1 | 2 | 0 |
| 30 Sep 22 | 0 | -4 | 3 | 0 |
| 30 Jun 22 | 0 | 0 | 3 | 0 |
| 31 Mar 22 | 0 | -3 | 5 | 0 |
| 31 Dec 21 | 0 | 2 | 4 | 0 |
Quality Earnings: VHAQ is currently unprofitable.
Growing Profit Margin: VHAQ is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if VHAQ's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare VHAQ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VHAQ is unprofitable, making it difficult to compare its past year earnings growth to the Capital Markets industry (3.3%).
Return on Equity
High ROE: VHAQ's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.